4.7 Article

Deferoxamine Attenuates White Matter Injury in a Piglet Intracerebral Hemorrhage Model

Journal

STROKE
Volume 45, Issue 1, Pages 290-292

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.113.003033

Keywords

brain edema; cerebral hemorrhage; deferoxamine; receptor-interacting protein serine-threonine kinase 1; tumor necrosis factor-alpha

Funding

  1. National Institutes of Health [NS-052510, NS-073595, NS-079157, NS-084049]

Ask authors/readers for more resources

Background and Purpose Deferoxamine reduces neuronal death in a piglet model of intracerebral hemorrhage (ICH). This study examined the effect of deferoxamine on perihematomal white matter edema in piglets. Methods ICH was induced by an injection of autologous blood into the right frontal lobe of piglets. In the first part of study, the time course of edema formation was determined. In the second part, the effects of deferoxamine on ICH-induced white matter edema, tumor necrosis factor , and receptor-interacting protein kinase 1 were examined. Results ICH resulted in marked brain edema and increased tumor necrosis factor and receptor-interacting protein kinase 1 levels in white matter. Systemic treatment with deferoxamine markedly reduced white matter tumor necrosis factor and receptor-interacting protein kinase 1 levels and attenuated white matter edema after ICH. Conclusions Deferoxamine reduces white matter edema, tumor necrosis factor , and receptor-interacting protein kinase 1 levels after ICH in piglets, suggesting deferoxamine is a potential effective therapeutic agent for patients with ICH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available